US Stock MarketDetailed Quotes

GIKLY GRIFOLS SA SPON ADR EA REPR 1/2 ORD SHS EUR0.50

Watchlist
  • 4.845
  • 0.0000.00%
15min DelayClose Jul 26 09:30 ET
6.58BMarket Cap98.88P/E (TTM)

About GRIFOLS SA SPON ADR EA REPR 1/2 ORD SHS EUR0.50 Company

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Company Profile

SymbolGIKLY
Company NameGRIFOLS SA SPON ADR EA REPR 1/2 ORD SHS EUR0.50
Listing DateJun 2, 2011
Founded1940
CEOMr. Jose Ignacio Abia Buenache
MarketPink Market
Employees23744
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
AddressAvinguda de la Generalitat, 152-158,Parc de Negocis Can Sant Joan,Sant Cugat del Vallès
CityBarcelona
ProvinceCatalonia
CountrySpain
Zip Code08174
Phone34-93-571-02-21

Company Executives

  • Name
  • Position
  • Salary
  • Jose Ignacio Abia Buenache
  • Director and Chief Executive Officer
  • --
  • Miguel Louzan
  • Chief Digital Information Officer
  • --
  • Camille Alpi
  • Chief Human Resources and Talent Officer
  • --
  • Raimon Grifols Roura
  • Vice Chairman of the Board and Chief Corporate Officer
  • --
  • Maria Teresa Rione Llano
  • Chief Communications Officer
  • --
  • Alfredo Arroyo Guerra
  • Chief Financial Officer
  • --
  • David Ian Bell
  • General Counsel, Chief Corporate Development, Legal and Data Protection Officer
  • --
  • Víctor Grifols Deu
  • Director and Chief Operating Officer
  • --
  • Dr. Jorg Schuttrumpf
  • Chief Scientific Innovation Officer
  • --
  • Daniel Fleta Coit
  • Chief Industrial Services Officer
  • --
  • Ignacio Ramal Subira
  • Chief Internal Audit and Enterprise Risk Manager
  • --
  • Lluis Pons Gomez
  • Senior Vice President, Strategy and COO Office
  • --
  • Laura Carratala Pena
  • Vice President, Bio Supplies
  • --
  • Francisco Javier Guix Huguet
  • Vice President, Healthcare Solutions
  • --
  • Jordi Balsells Valls
  • President, Plasma Procurement
  • --
  • Thomas H. Glanzmann
  • Executive Chairman of the Board
  • --
  • Dr. Antonio Martinez Martinez
  • President, Diagnostic Business Unit
  • --
  • Dr. Roland Wandeler, PhD
  • President, Biopharma Business Unit
  • --
  • Tomas Daga Gelabert
  • Director and Vice Secretary of the Board
  • --
  • Albert Grifols Coma-Cros
  • Director
  • --
  • James Costos
  • Independent Director
  • --
  • Enriqueta Felip Font
  • Independent Director
  • --
  • Carina Szpilka Lazaro
  • Lead Independent Director
  • --
  • Susana Gonzalez Rodriguez
  • Independent Director
  • --
  • Inigo Sanchez-Asiain Mardones
  • Independent Director
  • --
  • Montserrat Munoz Abellana
  • Independent Director
  • --
  • Nuria Martin Barnes
  • Secretary
  • --
  • Laura de la Cruz Galan
  • Vice Secretary
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg